Michael R Robinson
Overview
Explore the profile of Michael R Robinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
3855
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silverstein S, Oddone F, Kolko M, Brinkmann C, Christie W, Bicket A, et al.
Drugs
. 2025 Feb;
PMID: 39985740
Background: Bimatoprost implant 10 µg is an intracameral, biodegradable implant that slowly releases bimatoprost to lower intraocular pressure (IOP). This study was designed to evaluate safety and the duration of...
2.
Kolko M, Tatham A, Lim K, Wells A, Shiu M, Uy H, et al.
Am J Ophthalmol
. 2025 Jan;
272:19-37.
PMID: 39800203
Purpose: To evaluate the intraocular pressure (IOP)-lowering effect and safety of up to 2 bimatoprost implant administrations versus selective laser trabeculoplasty (SLT). Design: Phase 3 (Stage 2), randomized, 24-month, multicenter,...
3.
Nguyen A, Naidoo K, Ajouz L, Xu X, Zhao C, Robinson M, et al.
J Ocul Pharmacol Ther
. 2024 Aug;
40(9):562-570.
PMID: 39150383
Changes in meibum composition and quantity in meibomian gland dysfunction (MGD) result in tear film instability and dry eye. This exploratory study aimed to identify changes in (O-acyl)-ω-hydroxy fatty acid...
4.
Lee S, Nagar S, Rajagopalan L, Orilla W, Csaky K, Almazan A, et al.
J Ocul Pharmacol Ther
. 2024 Apr;
40(5):297-308.
PMID: 38687355
To investigate gel stent implantation with and without intraoperative sustained-release mitomycin C (MMC SR) in a rabbit model for gel stent implantation, and to examine aqueous humor outflow (AHO) postimplantation....
5.
Ajouz L, Hallak J, Naik R, Nguyen A, Zhao C, Robinson M, et al.
J Ocul Pharmacol Ther
. 2023 Nov;
40(1):48-56.
PMID: 37910805
This study was intended to characterize the impact of meibomian gland dysfunction (MGD) on patients' quality of life. In this prospective, multicenter, noninterventional clinical study (NCT01979887), eligible individuals (age ≥40...
6.
Ajouz L, Nguyen A, Zhao C, Robinson M, Nichols K
J Ocul Pharmacol Ther
. 2023 Aug;
39(9):611-621.
PMID: 37643299
Dry eye disease is attributed to impaired tear production and/or evaporative dry eye. Evaporative dry eye is frequently associated with meibomian gland dysfunction (MGD). The objective of this study was...
7.
Nagar S, Ajouz L, Nichols K, Kumar S, Zhao C, Naidoo K, et al.
Invest Ophthalmol Vis Sci
. 2023 Jul;
64(10):22.
PMID: 37466951
Purpose: Information on the relationship between meibum lipid composition and severity of meibomian gland dysfunction (MGD) is limited. The purpose of this study was to analyze the molecular components of...
8.
Kannarr S, El-Harazi S, Moshirfar M, Lievens C, Kim J, Peace J, et al.
Am J Ophthalmol
. 2023 May;
253:189-200.
PMID: 37149245
Purpose: To evaluate the safety, efficacy, and pharmacokinetics of pilocarpine hydrochloride 1.25% (Pilo hereafter) compared with vehicle when administered bilaterally, twice daily (6 hours apart) for 14 days in participants...
9.
Stamer W, Perkumas K, Kang M, Dibas M, Robinson M, Rhee D
Invest Ophthalmol Vis Sci
. 2023 Mar;
64(3):15.
PMID: 36877514
Purpose: The purpose of this study was to evaluate the effects of pharmacologically relevant bimatoprost and bimatoprost free acid (BFA) concentrations on matrix metalloproteinase (MMP) gene expression in cells from...
10.
Weinreb R, Bacharach J, Brubaker J, Medeiros F, Bejanian M, Bernstein P, et al.
J Ocul Pharmacol Ther
. 2022 Nov;
39(1):55-62.
PMID: 36378864
To evaluate the time course of biodegradation of an intracameral, biodegradable, sustained-release bimatoprost implant that lowers intraocular pressure without the need for daily eye drops. In 2 identically designed, randomized,...